Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1*0201

Human Molecular Genetics

Volumn 11, Issue 14, 2002, Pages 1585-1597

  Malcolm Taylor, G ^a   Dearden, Simon ^a   Ravetto, Paul ^a   Ayres, Michelle ^a   Watson, Pamela ^a   Hussain, Adiba ^a   Greaves, Mel ^b   Alexander, Freda ^c   Eden, Osborn B ^d  

^a ST MARY S HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AMINO ACID; HLA DP ANTIGEN; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; ONCOPROTEIN; PEPTIDE; TEL AML1 FUSION PROTEIN; TEL-AML1 FUSION PROTEIN; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ALLOTYPE; ANTIBODY COMBINING SITE; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMAN; INFANT; LEUKEMOGENESIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; RISK; SOLID TUMOR; STEM CELL; ACUTE LYMPHOCYTIC LEUKEMIA; BINDING SITE; BIOLOGICAL MODEL; CASE CONTROL STUDY; DIPLOIDY; GENE REARRANGEMENT; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; METABOLISM; PRESCHOOL CHILD; REFERENCE VALUE; T CELL LEUKEMIA;

BINDING SITES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DIPLOIDY; FEMALE; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HLA-DR ANTIGENS; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, T-CELL, ACUTE; MALE; MODELS, GENETIC; ONCOGENE PROTEINS, FUSION; PEPTIDES; POLYMORPHISM, GENETIC; REFERENCE VALUES;

EID: 0036647268     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.14.1585     Document Type: Article

References (83)

1. Childhood cancer incidence: Geographic and temporal variations
2. The international incidence of childhood cancer
3. Childhood leukaemia in The Netherlands, 1973-1986: Temporary variation of the incidence of acute lymphocytic leukaemia in young children
4. Descriptive epidemiology of childhood leukaemia
5. Incidence of cancer in children in the United States
6. Childhood cancer in Britain: The National Registry of Childhood Tumours and incidence rates 1978-1987
7. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukaemia
8. Geographical distribution of acute lymphoblastic leukaemia subtypes:second report of the collaborative group study
9. Acute lymphoblastic leukaemia in the UK by immunophenotype
10. Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype
11. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI
12. In utero rearrangements in the trithorax-related oncogene in infant leukaemias
13. Backtracking leukaemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots
14. Prenatal origin of acute lymphoblastic leukaemia in children
15. Molecular genetics, natural history and the demise of childhood leukaemia
16. An infectious etiology for common acute lymphoblastic leukemia in childhood?
17. Epidemiological evidence for an infective basis in childhood leukaemia
18. Aetiology of acute leukaemia
19. Antibodies to Epstein-Barr and other viruses in children with acute lymphoblastic leukaemia
20. Sero-epidemiological analysis of the risk of virus infections for childhood leukaemia
21. JC and BK virus sequences are not detectable in leukaemic samples from children with common acute lymphoblastic leukaemia
22. Investigation of leukemia cells from children with common acute lymphoblastic leukemia for genomic sequences of the primate polyomaviruses JC virus, BK virus, and simian virus 40
23. Screening for herpesvirus genomes in common acute lymphoblastic leukemia
24. Evidence from population mixing in British New Towns 1946-1985 of an infective basis for childhood leukaemia
25. High contact paternal occupations, infection and childhood leukaemia: Five studies of unusual population-mixing of adults
26. Wartime evacuation and mortality from childhood leukaemia in England and Wales in 1945-1949
27. Community lifestyle characteristics and risk of acute lymphoblastic leukaemia in children
28. Seasonality in the diagnosis of acute lymphocyctic leukaemia
29. Seasonal variations in the onset of childhood leukaemia and lymphoma
30. Spatial temporal patterns in childhood leukaemia: Further evidence for an infectious origin
31. Space-time clustering patterns in childhood leukaemia support a role for infection
32. Childhood leukemia and infectious diseases in the first year of life: A register-based case-control study
33. Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia
34. Pre- and perinatal risk factors for childhood leukaemia and other malignancies: A Scottish case control study
35. Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA
36. Haemophilus influenzae type B vaccination and risk of childhood leukaemia in a vaccine trial in Finland
37. Association of childhood leukaemia with factors related to the immune system
38. Breast-feeding and risk of childhood acute leukaemia
39. Reverse immunogenetics: From HLA-disease associations to vaccine candidates
40. HLA class II peptide binding specificity and autoimmunity
41. Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases
42. Binding domain regulation of MHC class II molecule assembly, trafficking, fate and function
43. Allelic loss in childhood acute lymphoblastic leukemia
44. Allelotype analysis of childhood acute lymphoblastic leukemia
45. HLA DNA class II typing by PCR-SSOP: 12th International Histocompatibility Workshop experience
46. Preliminary evidence of an association between HLA-DPB1*0201 and childhood common acute lymphoblastic leukaemia supports an infectious aetiology
47. The United Kingdom Childhood Cancer Study: Objectives, materials and methods
48. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci
49. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection
50. Heterozygote advantage for HLA class II-type in hepatitis B virus infection
51. Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine
52. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination
53. HLA-DP2. Self peptide sequence and binding properties
54. Rapid allelic diversification and intensified selection at antigen recognition sites of the Mhc class II DPB1 locus during hominoid evolution
55. Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia
56. Unravelling an HLA-DR association in childhood acute leukemia
57. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM)
58. A new predictive model for insulin-dependent diabetes mellitus susceptibility based on combinations of molecular HLA-DRB1 and HLA-DQB1 pockets
59. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region
60. Molecular analysis HLA-DQB1 alleles in childhood common acute lymphoblastic leukaemic
61. Use of cancer controls in case-control cancer studies
62. Cancer case-control studies with other cancers as controls
63. Selection of cases and controls
64. Childhood cancer and ethnic group in Britain: A United Kingdom Children's Cancer Study Group (UKCCSG) study
65. Genetic dissection of complex traits
66. Case-control studies of association in structured or admixed populations
67. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias
68. Hepatitis B and childhood acute lymphoblastic leukaemia
69. Detection of hepatitis B virus DNA sequences in bone marrow of children with leukaemia
70. HLA-DPB1*0201 allele is negatively associated with immunoglobulin E responsiveness specific for house dust mite allergens in Taiwan
71. Allergic disorders and the risk of childhood acute lymphoblastic leukemia (United States)
72. HLA-DPB1 glutamate 69: A genetic marker of beryllium disease
73. 69 HLA-DPB1 and DPA-1 alleles
74. HLA-DP molecules bind cobalt: A possible explanation for genetic association with hard metal disease
75. Augmentation of immune response by altered peptide ligands of the antigenic peptide in a human CD4+ T-cell clone reacting to TEL/AML1 fusion protein
76. Generation of tissue specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
77. Functional diversity of helper T lymphocytes
78. MHC genotype controls the capacity of ligand density to switch T helper (Th)-1/Th-2 priming in vivo
79. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997
80. Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology
81. Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes
82. Statistical aspects of the analysis of data from retrospective studies of disease